The Quebec Association of Gastroenterology position paper on colorectal cancer screening - 2003

Canadian Journal of Gastroenterology

Volumn 18, Issue 8, 2004, Pages 509-519

  Barkun, A N ^a   Jobin, Gilles ^b,e   Cousineau, G ^c   Dube S ^b   Lahaie, R ^c   Pare P ^d   Stein, B ^a   Wassef, R ^c  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^e L'Assoc des Gastro Enterol Quebec   (Canada)

Author keywords

Colonoscopy; Colorectal cancer; Fecal occult blood test; Guidelines; Screening

Indexed keywords

ADULT; AGED; BARIUM ENEMA; CANADA; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTROENTEROLOGY; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL SOCIETY; OCCULT BLOOD TEST; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; VIRTUAL REALITY;

EID: 4544230843     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/327858     Document Type: Review

References (74)

1. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
2. National Cancer Institute of Canada. Canadian Cancer Statistics, 2000. Toronto: National Cancer Institute of Canada, 2000.
3. Tierney RP, Ballantyne GH, Modlin IM. The adenoma to carcinoma sequence. Surg Gynecol Obstet 1990;171:81-94.
4. Morson BC, Dawson IMP. Gastrointestinal Pathology. Oxford: Blackwell Scientific, 1972.
5. Greene FL. Distribution of colorectal neoplasms. A left to right shift of polyps and cancer. Am Surg 1983;49:62-5.
6. Helwig EB. Ademnomas and the pathogenesis of cancer of the colon and rectum. Dis Colon Rectum 1959;2:5.
7. Prager ED, Swinton NW, Young JL, Veidenheimer MC, Corman ML. Follow-up study of patients with benign mucosal polyps discovered by proctosigmoidoscopy. Dis Colon Rectum 1974;17:322-4.
8. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975;36:2251-70.
9. Morson BC. The evolution of colorectal carcinoma. Clin Radiol 1984;35:425-31.
10. Moore J, Cowled P. Hereditary non-polyposis colorectal cancer syndrome. Aust N Z J Surg 1999;69:6-13.
11. Vasen HF, Griffioen G, Tops CM, et al. Familial adenomatous polyposis and its clinical surveillance. Neth J Med 1993;42:105-8.
12. McLeod RS. Screening strategies for colorectal cancer: A systematic review of the evidence. Can J Gastroenterol 2001;15:647-60.
13. Imperiale TF, Wagner DR, Lin CY, et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 2002;346:1781-5.
14. Benson IA. Recent and ongoing clinical trials for treating colorectal cancer. Exp Opin Invest Drugs 2002;11:871-80.
15. Battista RN. Conseil d'évaluation des technologies de la santé du Québec. Le dépistage du cancer colorectal. (CETS 99-2RF) Montreal: CETS, 1999:xx-146.
16. Canadian Task Force on Preventive Health Care. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001;24;165:206-8.
17. Goldbloom R, Battista RN. The periodic health examination: 1. Introduction. CMAJ 1986;134:721-3.
18. Ransohoff DF, Sandler RS. Clinical practice. Screening for colorectal cancer. N Engl J Med 2002;346:40-4.
19. Gazelle GS, McMahon PM, Scholz FJ. Screening for colorectal cancer. Radiology 2000;215:327-35.
20. Rex DK. Barium studies/virtual colonoscopy: The gastroenterologist's perspective. Gastrointest Endosc 2002;55(Suppl 7):S6,S33-6.
21. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
22. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
23. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
24. Mandel JS, Bond JH, Snover DC, et al. The University of Minnesota's Colon Cancer Control Study: Design and progress to date. In: Chamberlain J, Miller AB, eds. Screening for Gastrointestinal Cancer. Toronto: Huber, 1998:434-7.
25. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
26. Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet 1989;1:1160-4.
27. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
28. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994;29:468-73.
29. Kewenter J, Bjork S, Haglind E, et al. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1988;62:645-51.
30. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989;24:599-606.
31. Towler B, Irwig L, Glasziou P, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998;317:559-65.
32. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy? JAMA 1994;271:1011-3.
33. Blalock SJ, DeVellis BM, Sandler RS. Participation in fecal occult blood screening: A critical review. Prev Med 1987;16:9-18.
34. Friedman GD, Collen MF, Fireman BH. Multiphasic Health Checkup Evaluation: A 16-year follow-up. J Chronic Dis 1986;39:453-63.
35. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
36. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
37. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
38. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
39. Gilbertsen VA. Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer. Cancer 1974;34(Suppl):936-9.
40. Gilbertsen VA, Nelms JM. The prevention of invasive cancer of the rectum. Cancer 1978;41:1137-9.
41. Hertz R, Deddish M, Day E. Value of periodic examinations in detecting cancer of the colon and rectum. Postgrad Med 1960;27:290-4.
42. Verne JE, Aubrey R, Love SB, Talbot IC, Northover JM. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 1998;317:182-5.
43. Berry DP, Clarke P, Hardcastle JD, Vellacott KD. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br J Surg 1997;84:1274-6.
44. Rasmussen M, Kronborg O, Fenger C, Jorgensen OD. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study. Scand J Gastroenterol 1999;34:73-8.
45. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169-74.
46. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-60.
47. Atkin WS, Edwards R, Wardle J, et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001;8:137-44.
48. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
49. Lieberman D. ASGE Clinical Update: Colon Cancer Screening: Role of endoscopy. ASGE 2000;8:1-4.
50. Rex DK, Sledge GW, Harper PA, et al. Colonic adenomas in asymptomatic women with a history of breast cancer. Am J Gastroenterol 1993;88:2009-14.
51. Johnson DA, Gurney MS, Volpe RJ, et al. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol 1990;85:969-74.
52. Gazelle GS, McMahon PM, Scholz FJ. Screening for colorectal cancer. Radiology 2000;215:327-35.
53. Provenzale D. Cost-effectiveness of screening the average-risk population for colorectal cancer. Gastrointest Endosc Clin N Am 2002;12:93-109.
54. Crott R. The cost-effectiveness of screening for colorectal cancer. Exp Rev Pharmacoeconomics Outcomes Res 2001;1:89-98.
55. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: A systematic review for the US Preventive Services Task Force. Ann Intern Med 2002;137:96-104.
56. Loeve F, Brown ML, Boer R, et al. Endoscopic colorectal cancer screening: A cost-saving analysis. J Natl Cancer Inst 2000;92:557-63.
57. Whynes DK, Neilson AR, Walker AR, Hardcastle JD. Faecal occult blood screening for colorectal cancer: Is it cost-effective? Health Econ 1998;7:21-9.
58. Gyrd-Hansen D. Fecal occult blood tests. A cost-effectiveness analysis. Int J Technol Assess Health Care 1998;14:290-301.
59. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000;133:573-84.
60. Khandker RK, Dulski JD, Kilpatrick JB, et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care 2000;16:799-810.
61. Glick S, Wagner JL, Johnson CD. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. AJR Am J Roentgenol 1998;170:629-36.
62. McMahon PM, Bosch JL, Gleason S, et al. Cost-effectiveness of colorectal cancer screening. Radiology 2001;219:44-50.
63. Sorrentino D, Paduano R, Bernardis V, Piccolo A, Bartoli E. Colorectal cancer screening in Italy: Feasibility and cost-effectiveness in a model area. Eur J Gastroenterol Hepatol 1999;11:655-60.
64. Ness RM, Holmes AM, Klein R, Dittus R. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol 2000;95:1800-11.
65. Ransohoff DF, Lang CA. Cost effectiveness of one-time colonoscopy screening to reduce colorectal cancer mortality. Gastroenterology 1994;106:A24.
66. Norum J. Prevention of colorectal cancer: A cost-effectiveness approach to a screening model employing sigmoidoscopy. Ann Oncol 1998;9:613-8.
67. Geul KW, Bosman FT, van Blankenstein M, Grobbee DE, Wilson JH. Prevention of colorectal cancer. Costs and effectiveness of sigmoidoscopy. Scand J Gastroenterol Suppl 1997;223:79-87.
68. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284:1954-61.
69. US Preventative Services Task Force USPSTF. Screening for Colorectal Cancer. Guide to Clinical Preventative Services. Alexandria: International Medical Publishing Inc, 1996
70. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 2000;95:868-77.
71. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: Update 2001 - Testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75,7-80.
72. US Preventative Service Task Force USPSTF. Screening for colorectal cancer: Recommendation and rationale. Ann Intern Med 2002;137:129-31.
73. Cancer Care Ontario. Ontario expert panel on colorectal cancer. Final report of the Ontario expert panel on colorectal cancer, 1999. http://www.cancercare.on.ca/pdf/colorectal.pdf (Version current at July 19, 2004).
74. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale - Update based on new evidence. Gastroenterology 2003;124:544-60.